SHARx Teams Up with Mark Cuban's Cost Plus Drug Company to Expand Access to Specialty Medications

SHARx, a patient advocacy organization committed to supporting uninsured and underinsured Americans by providing diverse access options for high-cost maintenance and specialty medications, has embarked on a strategic collaboration with Mark Cuban's Cost Plus Drug Company. This partnership seeks to significantly broaden the reach of essential medications to individuals experiencing insurance gaps, thereby enhancing their ability to obtain and afford the treatments they need.